Sec Form 13G Filing - Beedie Investments Limited filing for - 2026-02-10

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Beneficial ownership described above is based upon 169,305,206 common shares of Issuer outstanding as of December 31, 2025, and assumes exercise of warrants to purchase 1,250,000 common shares of Issuer deemed to be beneficially owned by the reporting person (the "Warrants") into 1,250,000 common shares of Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Beneficial ownership described above is based upon 169,305,206 common shares of Issuer outstanding as of December 31, 2025, and assumes exercise of warrants to purchase 1,250,000 common shares of Issuer deemed to be beneficially owned by the reporting person (the "Warrants") into 1,250,000 common shares of Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Beneficial ownership described above is based upon 169,305,206 common shares of Issuer outstanding as of December 31, 2025, and assumes exercise of warrants to purchase 1,250,000 common shares of Issuer deemed to be beneficially owned by the reporting person (the "Warrants") into 1,250,000 common shares of Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Beneficial ownership described above is based upon 169,305,206 common shares of Issuer outstanding as of December 31, 2025, and assumes exercise of warrants to purchase 1,250,000 common shares of Issuer deemed to be beneficially owned by the reporting person (the "Warrants") into 1,250,000 common shares of Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Beneficial ownership described above is based upon 169,305,206 common shares of Issuer outstanding as of December 31, 2025, and assumes exercise of warrants to purchase 1,250,000 common shares of Issuer deemed to be beneficially owned by the reporting person (the "Warrants") into 1,250,000 common shares of Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Beneficial ownership described above is based upon 169,305,206 common shares of Issuer outstanding as of December 31, 2025, and assumes exercise of warrants to purchase 1,250,000 common shares of Issuer deemed to be beneficially owned by the reporting person (the "Warrants") into 1,250,000 common shares of Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Beneficial ownership described above is based upon 169,305,206 common shares of Issuer outstanding as of December 31, 2025, and assumes exercise of warrants to purchase 1,250,000 common shares of Issuer deemed to be beneficially owned by the reporting person (the "Warrants") into 1,250,000 common shares of Issuer.


SCHEDULE 13G


 
Beedie Investments Limited
 
Signature:/s/ Ryan Beedie
Name/Title:Ryan Beedie, President
Date:02/10/2026
 
Beedie Holdings Limited
 
Signature:/s/ Ryan Beedie
Name/Title:Ryan Beedie, President
Date:02/10/2026
 
Beedie (2023) Family Trust
 
Signature:/s/ Ryan Beedie
Name/Title:Ryan Beedie, President of 4358 Investments Limited, its Trustee
Date:02/10/2026
 
4358 Investments Limited
 
Signature:/s/ Ryan Beedie
Name/Title:Ryan Beedie, President
Date:02/10/2026
 
Ryan Beedie
 
Signature:/s/ Ryan Beedie
Name/Title:Ryan Beedie
Date:02/10/2026
 
Beedie Capital Investments Limited
 
Signature:/s/ Ryan Beedie
Name/Title:Ryan Beedie, President
Date:02/10/2026
 
Beedie Capital Holdings Limited
 
Signature:/s/ Ryan Beedie
Name/Title:Ryan Beedie, President
Date:02/10/2026
primary_doc.xml